MAP3K11
Mitogen-activated protein kinase kinase kinase 11
Also known as: M3K11_HUMAN, MEKK11, MLK3, PTK1, SPRK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16584
- Gene
- MAP3K11
- Ensembl
- ENSG00000173327
- Chromosome
- 11
- Canonical length
- 847 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Centriolar satellite,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the serine/threonine kinase family. This kinase contains a SH3 domain and a leucine zipper-basic motif. This kinase preferentially activates MAPK8/JNK kinase, and functions as a positive regulator of JNK signaling pathway. This kinase can directly phosphorylate, and activates IkappaB kinase alpha and beta, and is found to be involved in the transcription activity of NF-kappaB mediated by Rho family GTPases and CDC42. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
847 residues, UniProt reviewed canonical sequence.
>Q16584|MAP3K11
1 MEPLKSLFLK SPLGSWNGSG SGGGGGGGGG RPEGSPKAAG YANPVWTALF DYEPSGQDEL
61 ALRKGDRVEV LSRDAAISGD EGWWAGQVGG QVGIFPSNYV SRGGGPPPCE VASFQELRLE
121 EVIGIGGFGK VYRGSWRGEL VAVKAARQDP DEDISVTAES VRQEARLFAM LAHPNIIALK
181 AVCLEEPNLC LVMEYAAGGP LSRALAGRRV PPHVLVNWAV QIARGMHYLH CEALVPVIHR
241 DLKSNNILLL QPIESDDMEH KTLKITDFGL AREWHKTTQM SAAGTYAWMA PEVIKASTFS
301 KGSDVWSFGV LLWELLTGEV PYRGIDCLAV AYGVAVNKLT LPIPSTCPEP FAQLMADCWA
361 QDPHRRPDFA SILQQLEALE AQVLREMPRD SFHSMQEGWK REIQGLFDEL RAKEKELLSR
421 EEELTRAARE QRSQAEQLRR REHLLAQWEL EVFERELTLL LQQVDRERPH VRRRRGTFKR
481 SKLRARDGGE RISMPLDFKH RITVQASPGL DRRRNVFEVG PGDSPTFPRF RAIQLEPAEP
541 GQAWGRQSPR RLEDSSNGER RACWAWGPSS PKPGEAQNGR RRSRMDEATW YLDSDDSSPL
601 GSPSTPPALN GNPPRPSLEP EEPKRPVPAE RGSSSGTPKL IQRALLRGTA LLASLGLGRD
661 LQPPGGPGRE RGESPTTPPT PTPAPCPTEP PPSPLICFSL KTPDSPPTPA PLLLDLGIPV
721 GQRSAKSPRR EEEPRGGTVS PPPGTSRSAP GTPGTPRSPP LGLISRPRPS PLRSRIDPWS
781 FVSAGPRPSP LPSPQPAPRR APWTLFPDSD PFWDSPPANP FQGGPQDCRA QTKDMGAQAP
841 WVPEAGPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP3K11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- liver: 93 nTPM
- spleen: 75 nTPM
- lung: 61 nTPM
- heart muscle: 52 nTPM
- spinal cord: 51 nTPM
- small intestine: 49 nTPM
Single-cell type
- neutrophils: 129 nCPM
- late spermatids: 110 nCPM
- enterocytes: 107 nCPM
- hofbauer cells: 88 nCPM
- colonocytes: 86 nCPM
- vascular endothelial cells: 76 nCPM
Immune cell
- neutrophil: 17 nTPM
- non-classical monocyte: 16 nTPM
- intermediate monocyte: 15 nTPM
- eosinophil: 13 nTPM
- classical monocyte: 11 nTPM
- myeloid DC: 10 nTPM
Brain region
- white matter: 91 nTPM
- basal ganglia: 74 nTPM
- midbrain: 72 nTPM
- thalamus: 72 nTPM
- medulla oblongata: 70 nTPM
- cerebral cortex: 68 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAP3K11.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 128 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on MAP3K11 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.9
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell cycle G1/S phase transition
- JNK cascade
- MAPK cascade
- microtubule-based process
- positive regulation of JNK cascade
- positive regulation of JUN kinase activity
- positive regulation of neuron apoptotic process
- protein autophosphorylation
- protein phosphorylation
Molecular functions
- ATP binding
- identical protein binding
- JUN kinase kinase kinase activity
- MAP kinase kinase kinase activity
- mitogen-activated protein kinase kinase binding
- mitogen-activated protein kinase kinase kinase binding
- protein homodimerization activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- SH3 domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Mitogen-activated protein (MAP) kinase kinase kinase, MLK1-4
- Protein kinase, ATP binding site
- MLK1-3, SH3 domain
- SH3-like domain superfamily
- Serine/Threonine Kinases and Pseudokinases
- Protein tyrosine and serine/threonine kinase
- Variant SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP3K11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP3K11 as an antibody target. Whether an autoantibody or antibody against MAP3K11 could matter depends on whether native MAP3K11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP3K11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP3K11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...